𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selegiline and mortality in Parkinson's disease: Another view

✍ Scribed by A. J. Lees; J. Head; Y. Ben Shlomo

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
266 KB
Volume
41
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selegiline and mortality in Parkinson's
Selegiline and mortality in Parkinson's disease
✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran

Entacapone and motor fluctuations in Par
Entacapone and motor fluctuations in Parkinson's disease
✍ Jack E. Riggs πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

There are some confusing details in the recent Annals article by the Parkinson Study Group (PSG), concerning the use of entacapone.'